This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryuzaki, M. Articles by Bishop, V. S. Search for Related Content PubMed PubMed Citation Articles by Ryuzaki, M. Articles by Bishop, V. S.

(Hypertension. 1997;29:576-582.)
© 1997 American Heart Association, Inc.

Articles

Sympathoexcitatory Response to Cyclosporin A and Baroreflex Resetting

Munekazu Ryuzaki; Linda K. Stahl; Teresa Lyson; Ronald G. Victor; Vernon S. Bishop

the Kidney Disease Medical Center, Saitama (Japan) Medical School (M.R.); Department of Physiology, The University of Texas Health Science Center at San Antonio (L.K.S., V.S.B.); Physical Medicine and Rehabilitation Associates, Austin, Tex (T.L.); and the Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas (R.G.V.).

We postulate that the sympathoexcitatory response associated with the immunosuppressive agent cyclosporin A is due to an upward resetting of the arterial baroreflex. We performed studies in conscious intact and sinoaortic-denervated rabbits instrumented with catheters and renal nerve electrodes. In intact rabbits, cyclosporin A (20 mg/kg IV, 30 minutes) produced significant increases in renal sympathetic nerve activity (100% to 269±74%, P<.05) but did not increase mean arterial pressure. In intact rabbits, we determined arterial baroreflex curves relating renal sympathetic nerve activity and heart rate to mean arterial pressure by producing ramp increases (intravenous phenylephrine) and decreases (intravenous nitroprusside) in mean arterial pressure. Cyclosporin A treatment produced a shift of the midrange of the baroreflex control of heart rate (78.0±4.1 to 84.6±4.7 mm Hg, P<.05) and renal sympathetic nerve activity (74.6±3.9 to 87.0±4.8 mm Hg, P<.05). Vehicle administration produced no effects on arterial baroreflex curves relating renal sympathetic nerve activity and heart rate to mean arterial pressure. Compared with vehicle treatment, cyclosporin A reduced the maximum gain of heart rate (-5.6±0.6 versus -3.1±0.8 beats per minute per millimeter of mercury, P<.05) but had no effect on the maximum gain of renal sympathetic nerve activity. In conscious sinoaortic-denervated rabbits, cyclosporin A had no effect on mean arterial pressure (95.7±7.3 to 91.8±10.8 mm Hg), renal sympathetic nerve activity (100% to 110±6%), and heart rate (287±10 to 279±8 beats per minute). However, when the same sinoaortic-denervated rabbits were anesthetized with sodium pentobarbital, cyclosporin A (20 mg/kg IV) produced increases in renal sympathetic nerve activity (100% to 189±27%). These data indicate (1) that the sympathoexcitatory response to cyclosporin A depends on baroreceptor afferent input in the conscious state and (2) that this response involves an upward resetting of the arterial baroreflex.

Key Words: cyclosporines • baroreflex • resetting • hypertension, experimental • neuroregulators

This article has been cited by other articles:

				A. Nishiyama, H. Kobori, T. Fukui, G.-X. Zhang, L. Yao, M. Rahman, H. Hitomi, H. Kiyomoto, T. Shokoji, S. Kimura, et al. Role of Angiotensin II and Reactive Oxygen Species in Cyclosporine A-Dependent Hypertension Hypertension, October 1, 2003; 42(4): 754 - 760. [Abstract] [Full Text] [PDF]

				H. A. Shaltout and A. A. Abdel-Rahman Cyclosporine Induces Progressive Attenuation of Baroreceptor Heart Rate Response and Cumulative Pressor Response in Conscious Unrestrained Rats J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 966 - 973. [Abstract] [Full Text] [PDF]

				M. M. El-Mas, E. A. Afify, A. G. Omar, and F. M. Sharabi Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 346 - 354. [Abstract] [Full Text] [PDF]

				G. LIGTENBERG, R. J. HENÉ, P. J. BLANKESTIJN, and H. A. KOOMANS Cardiovascular Risk Factors in Renal Transplant Patients: Cyclosporin A Versus Tacrolimus J. Am. Soc. Nephrol., February 1, 2001; 12(2): 368 - 373. [Abstract] [Full Text]

				A. Virdis, L. Ghiadoni, S. Pinto, M. Lombardo, F. Petraglia, A. Gennazzani, S. Buralli, S. Taddei, and A. Salvetti Mechanisms Responsible for Endothelial Dysfunction Associated With Acute Estrogen Deprivation in Normotensive Women Circulation, May 16, 2000; 101(19): 2258 - 2263. [Abstract] [Full Text] [PDF]

				Z. Zhong, H. D. Connor, M. Yin, N. Moss, R. P. Mason, H. Bunzendahl, D. T. Forman, and R. G. Thurman Dietary Glycine and Renal Denervation Prevents Cyclosporin A-Induced Hydroxyl Radical Production in Rat Kidney Mol. Pharmacol., September 1, 1999; 56(3): 455 - 463. [Abstract] [Full Text]